Navigation Links
Arbor Vita rapid H5N1 flu diagnostic presented at ICEID meeting
Date:3/27/2008

H5N1 isolates from avian and human sources were tested with the AVC assay. Results of the AVC assay were presented at ICEID that showed no false positives against the respiratory clinical panel. Of the 28 H5N1 cultures tested, 26 gave positive results on the assay (sensitivity = 93%).

The researchers concluded that the PDZ based assay produced by AVC shows promise as a useful diagnostic in our vigilance against avian influenza. The sensitivity of the assay towards avian strains is robust and the format of the test favors easy deployment. NHRC and NAMRU3 will continue to collaborate to evaluate this assay against other grown strains (H7, H9 etc.) as well as in actual outbreak situations.


'/>"/>

Contact: Debra Bannister
530-676-8001
Arbor Vita Corporation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Coral reef fish harbor an unexpectedly high biodiversity of parasites
2. From brains to behavior: Cold Spring Harbor Protocols features methods for neuroscience research
3. Cold Spring Harbor Protocols highlights a method that captures cell growth and activity
4. Cold Spring Harbor Laboratorys lung cancer research program awarded $100,000 grant
5. Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology
6. RNA-based methods for developmental studies are featured in Cold Spring Harbor Protocols
7. San Diego Harbor Police Deploy BIO-key(R) Automated Vehicle Location System
8. Popular apple variety harbors unusual cell growth
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. New decontamination system kills anthrax rapidly without lingering effects
11. New chemically-sensitive MRI scan may bypass some invasive diagnostic tests in next decade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... --NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the growing mobile commerce market, announces the launch ... part of its 2015 marketing and branding initiatives for ... consumer website for Wocketwallet.com earlier this month. ... "Our new corporate website naturally showcases our premiere consumer ...
(Date:2/5/2015)... 2015  It is gratifying to see that the ... genomic science as a means to better understand human ... I was honored to participate in today,s White House ... Since the 1980s my teams have ... first sequenced genome of a free living organism, the ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... the University of Pennsylvania School of Medicine discovered that ... the internal molecular clock in mammals. What's more, this ... shed light on circadian rhythm disorders, including bipolar disorder. ... of metabolism, are reported in this week's issue of ...
... human bocavirus was found in nearly 5 percent of ... children. Researchers from the Centers for Disease Control ... Conference on Emerging Infectious Diseases , "Our preliminary data ... in Thailand, especially among young children," says Alicia Fry, ...
... the genome sequence of the bacterial pathogen Haemophilus ... of many other large, complex, medically, and commercially ... , However, the techniques used to derive these ... be unaware of potential errors lurking within the ...
Cached Biology News:Clock molecule's sensitivity to lithium sheds light on bipolar disorder 2Bocavirus infection may be associated with pneumonia in Thailand, especially in children 2Study suggests that publicly available genome data may contain small but significant errors 2
(Date:3/4/2015)...   ... Therapie, Strahlendosismanagement und IT-Lösungen für die gesamte Kette ... (NYSE: PHG, AEX: PHIA) gab heute seine ... bekannt, der vom 4. bis 8. März in ... Nr. 102 and 110 wird das Unternehmen ...
(Date:3/3/2015)... 2015 NASA astronaut Scott Kelly , who ... spend a year living and working on the International Space ... to 7 a.m. EDT Monday, March 9. Kelly ... completes the final weeks of his training. The interviews will ... Television highlighting his mission training and previous spaceflights. ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... "Gene Therapy Market, 2015 - 2025" report ... Market, 2015-2025" report provides an extensive study on the ... has been carried out in this field for over ... (four available in Asian markets; one approved in the ...
(Date:3/3/2015)... 2015 Adaptive Biotechnologies announced today that ... Board of Director as Chair of the Audit Committee. ... Chad oversees all finance, treasury and accounting functions. Since ... finance, treasury and accounting functions, and led the finance ... 2013, he was named Puget Sound Business Journal,s CFO ...
Breaking Biology Technology:Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2
... Acquisition Extends the Company,s Suite of Products and Increases ... LAUDERDALE, Fla. and PHILADELPHIA, June 23 OmniComm Systems, ... in integrated electronic data capture (EDC) solutions for clinical ... ("ERT"), a global provider of technology and services that ...
... Pursue All Pharmaceutical and Health-Oriented Nutraceutical Uses of Naturlose ... Incorporated (Nasdaq: SPEX ), an innovator in ... and regulatory consulting services to food, supplement, biotechnology and ... 1996 license agreement pursuant to which it granted Arla ...
... YM BioSciences Inc. (NYSE Amex: YMI , ... that identifies and advances a diverse portfolio of ... today reported that its licensee for nimotuzumab, Daiichi-Sankyo ... commenced enrollment of a Phase II trial evaluating ...
Cached Biology Technology:OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology 2OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology 3OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology 4Spherix Announces Termination of Arla License Agreement 2Spherix Announces Termination of Arla License Agreement 3Spherix Announces Termination of Arla License Agreement 4YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 2YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 3YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 4YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB 5
... of the routine trace metal analytical lab ... and simple to use instrumentation. The 7500ce ... challenging sample matrices found in the environmental ... toughest analytical challenges found in the clinical, ...
Polio component type I...
Choriongonadotropin (human, hCG)...
Complement factor B (human)...
Biology Products: